RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AFT Pharmaceuticals Stock

AFT Pharmaceuticals Market capitalization 2025

AFT Pharmaceuticals Market capitalization

309.36 M NZD

Ticker

AFT.NZ

ISIN

NZAFTE0001S4

WKN

A2DVUC

In 2025, AFT Pharmaceuticals's market cap stood at 309.36 M NZD, a -21.75% increase from the 395.35 M NZD market cap in the previous year.

The AFT Pharmaceuticals Market capitalization history

YEARMarket Capitalization (undefined NZD)
2024329.16
2023369.36
2022389.85
2021467.19
2020428.84
2019277.87
2018229.51
2017243.09
2016287.09
2015305.03
2014-
2013-
2012-

AFT Pharmaceuticals Aktienanalyse

What does AFT Pharmaceuticals do?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring AFT Pharmaceuticals's Market Capitalization

AFT Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of AFT Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

AFT Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in AFT Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about AFT Pharmaceuticals stock

What is the current AFT Pharmaceuticals market capitalization?

The current market capitalization of AFT Pharmaceuticals is 309.36 M NZD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like AFT Pharmaceuticals.

How has the market capitalization of AFT Pharmaceuticals developed in recent years?

The market capitalization of AFT Pharmaceuticals has increased/decreased by -21.75% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of AFT Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of AFT Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of AFT Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does AFT Pharmaceuticals pay?

Over the past 12 months, AFT Pharmaceuticals paid a dividend of 0.02 NZD . This corresponds to a dividend yield of about 0.54 %. For the coming 12 months, AFT Pharmaceuticals is expected to pay a dividend of 0.02 NZD.

What is the dividend yield of AFT Pharmaceuticals?

The current dividend yield of AFT Pharmaceuticals is 0.54 %.

When does AFT Pharmaceuticals pay dividends?

AFT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AFT Pharmaceuticals?

AFT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of AFT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0.02 NZD are expected. This corresponds to a dividend yield of 0.54 %.

In which sector is AFT Pharmaceuticals located?

AFT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFT Pharmaceuticals from 7/4/2024 amounting to 0.016 NZD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did AFT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of AFT Pharmaceuticals in the year 2024?

In the year 2024, AFT Pharmaceuticals distributed 0.011 NZD as dividends.

In which currency does AFT Pharmaceuticals pay out the dividend?

The dividends of AFT Pharmaceuticals are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AFT Pharmaceuticals

Our stock analysis for AFT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AFT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.